Turanabol

Dragon Pharma
💊
Turanabol Dragon Pharma
Oral Turinabol (4-CDHMT) 20 mg/tab · 17α-Alkylated · Non-Aromatizing
🧬
Compound
4-Chloro-DHMT (Tbol)
Dianabol derivative · no E2 · no DHT
Aromatization
None — zero E2 conversion
no DHT conversion · no water retention
📈
Profile
Lean & Dry · SHBG suppression
anabolic:androgenic ≈ 100:6
🎯
User Level
Beginner–Advanced
liver support mandatory

Typical Dose
40–60 mg/day
2–3 tabs · once daily
Administration
Oral · Once Daily
half-life ~16 hours
Cycle Length
6–8 weeks
solo or kickstart
Lab Tested
$90.00
$90.00
In Stock
Manufacturer Dragon Pharma
Brand Turinabol
Substance 4-Chlorodehydromethyltestosterone
Concentration 20 mg/tab
Pack Size 100 tabs
Shipping

Turanabol Dragon Pharma — Overview

Turanabol Dragon Pharma delivers 4-Chlorodehydromethyltestosterone (Oral Turinabol, Tbol) at 20 mg per tablet — the same compound developed and used systematically by the East German national sports program throughout the 1970s and 1980s for producing lean, dry athletic performance gains without the estrogenic mass and water accumulation of Dianabol. The 4-chloro modification on the Dianabol backbone eliminates aromatization completely and blocks DHT conversion, leaving a highly anabolic compound with an anabolic:androgenic ratio of approximately 100:6. The result is consistent lean mass accrual, moderate strength improvements, SHBG suppression that raises free testosterone levels, and no water retention — all within a twice-daily or once-daily oral dosing schedule. Available at Steroid Warehouse alongside single-compound orals including Dianabol 20, Anavar 50, and Winstrol 50 for users who want to compare the dry-gains oral class directly.

4-CDHMT · 20 mg/tab · 17α-Alkylated Non-Aromatizing · No DHT SHBG Suppression Lean Bulk Recomp Kickstart Beginner–Advanced

About the Compound: Oral Turinabol (4-CDHMT)

  • Structural origin and what the 4-chloro modification changes — Turanabol is Dianabol (methandrostenolone) with a 4-chloro substituent added to the A-ring; this single change eliminates aromatization to estradiol, blocks 5α-reduction to DHT, and substantially reduces androgenic activity while preserving anabolic receptor binding; the compound cannot produce estrogen-derived water retention, gynecomastia, or DHT-mediated hair or prostate effects from its own metabolism
  • Anabolic:androgenic ratio ≈ 100:6 with SHBG suppression — the very low androgenic score makes it one of the most anabolically selective oral AAS available; additionally, Tbol binds SHBG with moderate affinity, reducing bound testosterone and raising free testosterone levels when stacked with a testosterone base; this SHBG-displacement effect amplifies the anabolic environment beyond what Tbol's own AR binding produces
  • 17α-Alkylated oral with ~16-hour half-life — the 17α-alkyl group enables oral bioavailability by resisting first-pass hepatic metabolism; it also creates measurable hepatic stress, making liver protection mandatory; at ~16-hour half-life, once-daily dosing is effective for stable plasma levels; twice-daily split dosing (morning and pre-workout) is an option for minimizing peak-to-trough variation on higher doses
  • Fast-clearance oral with a long detection window — active compound clears within 24–48 hours of the last dose; however, specific Tbol urinary metabolites (4-chloro-17β-hydroxymethyltestosterone) remain detectable by WADA-accredited labs for 12 months or longer; this detection window is compound-specific and substantially longer than Dianabol or Winstrol
Active Substance
4-Chlorodehydromethyltestosterone
Concentration
20 mg/tab
Anabolic:Androgenic
≈ 100:6
Aromatization
None — zero E2
DHT Conversion
None — 4-chloro blocked
Half-Life
~16 hours · oral once daily

What Turanabol Does

  • Lean, water-free mass accrual — zero aromatization means no E2-driven subcutaneous water accumulation; mass gained on Tbol is dense and retainable post-cycle; gains are moderate in absolute volume compared to Dianabol but significantly drier and of higher quality; typical 6–8 week gains at 40–60 mg/day are 3–6 kg of lean tissue when diet is in surplus
  • Strength improvements without water-assisted numbers — the strength increase from Tbol is real but modest relative to wet compounds; it is AR-mediated and neuromuscular, not inflated by intramuscular glycogen or water weight; users transitioning from Dianabol to Tbol often report that Tbol strength gains feel more sustainable and better maintained after the cycle ends
  • SHBG suppression amplifying free testosterone — when Tbol is stacked with a testosterone base, its SHBG-binding activity displaces testosterone from the carrier protein, raising the free fraction of circulating testosterone; this synergy makes Tbol more effective as a stack component than as a solo compound and is the pharmacological basis for its historical use alongside testosterone in athletic programs
  • Body recomposition in caloric maintenance — the non-aromatizing anabolic profile combined with mild androgenic activity supports simultaneous fat reduction and lean mass retention; recomp outcomes are realistic at 40–60 mg/day in 8-week protocols where caloric intake is at or near maintenance; superior in this application to Dianabol, which requires surplus feeding to justify its stronger estrogenic and androgenic burden

Who It's For

  • Key differentiator from the dry-gains oral category — Turanabol sits between Anavar (too weak and expensive per mg) and Winstrol (too dry, joint stress, more hepatotoxic) in the non-aromatizing oral spectrum; it offers meaningfully stronger anabolic output than Anavar at lower cost, without the connective tissue drying and cholesterol suppression severity of Winstrol; it is the most practical non-aromatizing oral for a first or second injectable cycle kickstart
  • Best scenario — users starting their first testosterone-based injectable cycle who want a non-aromatizing oral kickstart that is pharmacologically active from week one while the injectable reaches steady state; athletes running lean bulk or recomp cycles where water retention, gynecomastia risk, and DHT-mediated androgenic sides are all to be avoided; intermediate users who want to add a mild second oral to a cycle without stacking a second aromatizing compound
  • Choose something else instead — users wanting maximum rapid mass and strength gains in the shortest window should choose Dianabol 20 Dragon Pharma — Tbol cannot match its week-2 strength numbers; users in the final 4–6 weeks of contest prep who need maximum hardness and striations should choose Winstrol 50 Dragon Pharma; users prioritizing joint lubrication and the mildest possible androgenic profile should choose Anavar 50 Dragon Pharma

Turanabol vs Alternatives

Compound Key Differences Choose Turanabol When Choose Alternative When
Dianabol 20 Dragon Pharma
Methandrostenolone 20 mg/tab
Aromatizes significantly; substantial water retention; faster and larger strength gains in weeks 1–4; more androgenic (acne, hair risk); AI required; superior as mass-building kickstart where water gain is tolerated A dry, non-aromatizing kickstart or lean bulk oral is the goal and AI management overhead is to be minimized; or when the cycle is already aromatizing-compound heavy Maximum week-2 to week-4 strength numbers are the priority and wet gains are acceptable; Dbol produces 15–20% more raw strength output in the first 4 weeks
Anavar 50 Dragon Pharma
Oxandrolone 50 mg/tab
DHT derivative (not 17-CDHMT); similarly non-aromatizing and dry; joint-lubricating at moderate doses; weaker absolute anabolic output mg-for-mg; significantly higher cost per effective dose; preferred for women and cutting finishers due to lower virilization risk Better mg-for-mg anabolic return at lower cost; 6–8 week kickstart where Anavar's mildness is not the priority Joint health maintenance during a dry cycle is a concern (Anavar's DHT activity supports synovial fluid); female protocols or anyone with documented DHT-pathway hair sensitivity choosing between these two orals
Winstrol 50 Dragon Pharma
Stanozolol 50 mg/tab
Similar non-aromatizing dry profile but stronger androgenic activity and more pronounced connective tissue desiccation; superior hardness and vascularity output in final contest-prep weeks; higher HDL suppression; joint dryness at high doses is a common complaint not seen with Tbol Lean bulk, recomp, or kickstart phases where joint comfort is important and contest-prep hardening is not yet the goal Final 4–6 weeks pre-contest where maximum striation and hardness are the objective and joint dryness is manageable with E2 control and Ecosprin

Combinations

Goal Stack Notes
Solo lean bulk (beginner oral-only) Turanabol 40–60 mg/day (2–3 tabs) × 6–8 weeks + LIV.52 Dragon Pharma 2 tabs twice daily throughout Suitable for first oral cycle without injectables; HPG suppression at 40–60 mg/day is moderate but real; a short PCT is required; no AI needed as Tbol produces no E2; liver support mandatory for the full cycle duration; keep cycle to 6 weeks maximum for the first run
Kickstart to long injectable cycle Turanabol 40 mg/day (weeks 1–6) + Enantat 250 Dragon Pharma 500 mg/week (weeks 1–14) + Arimidex Dragon Pharma 0.5 mg EOD + LIV.52 2 tabs twice daily (weeks 1–6) Tbol provides anabolic activity from week one while Enantat 250 builds to steady state in weeks 2–3; the SHBG-displacement synergy of Tbol + testosterone raises free testosterone during the kickstart window; drop Tbol at week 6; AI dose confirmed by E2 bloodwork at week 3–4; Tbol contributes no additional aromatization to manage
Lean recomp injectable stack Turanabol 40 mg/day + Enantat 250 400 mg/week + NPP 150 Dragon Pharma 300 mg/week + Arimidex 0.5 mg EOD + Caberlin 0.25 mg 2×/week + LIV.52 (weeks Tbol is active) NPP 150 adds nandrolone's joint support and lean mass stimulus; Tbol adds SHBG suppression and a non-aromatizing anabolic layer on top; Caberlin from week one for the 19-Nor prolactin load from NPP; confirm E2 and prolactin at week 4; Tbol for the first 6 weeks then drop
Pre-contest dry stack Turanabol 60 mg/day (3 tabs) + Enantat 250 400 mg/week + Masteron 200 Dragon Pharma 400 mg/week + Aromasin Dragon Pharma 12.5 mg EOD + LIV.52 throughout Tbol + Masteron 200 + Test E with Aromasin produces a low-water, high-hardness environment; Masteron's DHT anti-estrogenic overlay complements Tbol's zero-E2 profile; confirm lipids at week 6 — the combined HDL-suppressive load of three compounds is significant; no Caberlin needed (no 19-Nor in stack)
Advanced lean mass + test base extension Turanabol 60 mg/day (weeks 1–8) + Enantat 250 500 mg/week (weeks 1–16) + Masteron 200 400 mg/week (weeks 9–16) + Aromasin 12.5 mg EOD + LIV.52 (weeks 1–8) Tbol covers the first 8 weeks of a 16-week cycle as the oral anabolic layer; Masteron 200 takes over weeks 9–16 as the hardening compound for the final run-in; Tbol is dropped when Masteron begins; confirm ALT/AST at week 4 and week 8 during Tbol active phase; lipid panel at weeks 8 and 14

Side Effects & Management

What May Occur Background How to Handle It
Hepatic stress (ALT/AST elevation) 17α-Alkylation enables oral bioavailability at the cost of hepatic metabolism load; ALT/AST elevation is dose- and duration-dependent; Tbol is considered milder than Dianabol or Anadrol in absolute hepatotoxicity but cumulative stress at 60–80 mg/day over 8 weeks is clinically significant LIV.52 Dragon Pharma 2 tabs twice daily throughout the oral phase; ALT/AST at baseline, week 4, and end of cycle; ALT/AST >3× upper limit of normal: reduce dose immediately; >5×: stop compound and allow recovery before restarting; avoid alcohol and hepatotoxic medications during the cycle
Lipid suppression (HDL reduction, LDL elevation) Oral 17α-alkylated AAS suppress hepatic HDL production directly via liver first-pass metabolism; Tbol's HDL impact is moderate; stacking with other lipid-unfriendly compounds (Masteron, Winstrol, Trenbolone) significantly worsens the combined lipid profile Lipid panel at baseline and week 6–8; HDL <35 mg/dL or LDL >160: Atorvastatin 40 mg Dragon Pharma or Rosulip (Rosuvastatin) 10 mg/day; omega-3 3–4 g/day throughout
HPG axis suppression Tbol suppresses LH and FSH via hypothalamic feedback; at 40–60 mg/day, suppression is meaningful within 2–3 weeks and complete within 4 weeks; solo oral cycles without a testosterone base will experience endogenous testosterone decline throughout the cycle For solo cycles: begin PCT 24–48 hours after last dose; for Tbol + injectable cycles: PCT timing follows the injectable ester clearance; Nolvadex Dragon Pharma 40/20/20/20 mg/day; confirm LH, FSH, and total testosterone at 4–6 weeks post-PCT
Blood pressure elevation Mild androgenic activity and modest RBC stimulation produce a minor BP increase; less pronounced than with stronger androgens or aromatizing compounds; BP impact is amplified in multi-compound stacks including injectables Weekly home cuff monitoring; target <130/85 mmHg; Ecosprin (Aspirin) 75 mg/day for cardiovascular support; persistent >140/90: Amlip (Amlodipine) 5 mg/day
Androgenic effects (acne, oily skin) Despite the low androgenic ratio of 6, dose-dependent androgenic activity is present; acne is the most common androgenic complaint, particularly in genetically susceptible users; hair loss risk is low given the absence of DHT conversion, unlike with testosterone or Dianabol Mild: topical benzoyl peroxide or salicylic acid cleansers; moderate-severe: Accutane Dragon Pharma 10–20 mg/day; note that finasteride does not block Tbol's direct androgenic activity (no DHT conversion pathway)
Estrogenic effects (from testosterone base) Tbol itself produces zero E2; any estrogenic effects in a Tbol + testosterone stack come entirely from the testosterone component; Tbol's SHBG displacement may slightly amplify the free testosterone pool available for aromatization AI required only when a testosterone base is part of the stack; Arimidex Dragon Pharma 0.5 mg EOD; dose confirmed by E2 bloodwork at week 3–4; solo Tbol cycles require no AI

Bloodwork Monitoring

Lab When to Test Target & Action Threshold
ALT & AST (Liver Enzymes) Baseline; week 4; end of cycle Target <2× ULN — >3× ULN: reduce dose and retest in 2 weeks; >5× ULN: discontinue immediately and allow full recovery before any further 17α-alkylated oral use
Lipid Panel (HDL, LDL, Total Cholesterol) Baseline; week 6 HDL >40 mg/dL · LDL <130 mg/dL — HDL <35 or LDL >160: initiate statin; re-test 4 weeks post-intervention; omega-3 supplementation throughout
Estradiol (E2) Week 3–4 (when stacked with testosterone base only) Target 20–40 pg/mL — not relevant for solo Tbol cycles (zero Tbol E2 contribution); if stacked with Test E: confirm AI dose by lab, not symptoms
Blood Pressure Weekly (home cuff) Target <130/85 mmHg — persistent >140/90: Amlip 5 mg/day; if adding Sartel: Sartel (Telmisartan) 40 mg/day
Hematocrit & Hemoglobin Baseline; end of cycle Hematocrit <50% — Tbol has mild erythropoietic activity; solo Tbol cycles rarely reach clinical thresholds; monitor if stacking with injectables that add their own hematocrit contribution
LH & FSH End of PCT Both recovering toward mid-normal range — persistently suppressed at PCT week 4: extend SERM by 2 weeks; consider adding HCG if recovery is incomplete
Total Testosterone 4–6 weeks post-PCT >400 ng/dL confirms HPG recovery — <300 ng/dL at 6 weeks post-PCT with flat LH/FSH: specialist assessment warranted

Post-Cycle Recovery

For solo Tbol cycles, Tbol's ~16-hour half-life means the compound clears within 24–48 hours of the last dose. PCT begins the day after the last tablet. For Tbol + injectable combination cycles, PCT timing follows the injectable ester clearance window.

Compound Protocol Notes
HCG 5000 IU Dragon Pharma 500 IU EOD × 10 days before SERM start; use when Tbol was run alongside a testosterone base for >8 weeks Not mandatory for short solo Tbol-only cycles (≤6 weeks); strongly recommended for any cycle that included a testosterone injectable alongside Tbol; HCG bridges the gap between injectable clearance and SERM onset
Nolvadex Dragon Pharma 40 mg/day weeks 1–2; 20 mg/day weeks 3–4. Start the day after last Tbol dose (solo cycle) or 14 days post-last-injection (injectable combination cycle) Primary SERM for all Tbol PCT scenarios; 4-week protocol is sufficient for solo oral cycles; extend to 6 weeks for Tbol + long-ester injectable combination cycles; confirm LH/FSH at week 4
Clomid Dragon Pharma 50/25/25/25 mg/day × 4 weeks alongside Nolvadex for multi-compound or cycle lengths >10 weeks Add to Nolvadex when prior solo Nolvadex recovery was incomplete or when the Tbol cycle ran alongside multiple suppressive injectables; single short Tbol-only cycles typically do not require Clomid
Enclomiphene Dragon Pharma 25 mg/day × 4–6 weeks as alternative to Clomid Preferred when Clomid-associated mood or visual side effects are a concern; equivalent LH stimulation with improved tolerability; suitable replacement for Clomid in any Tbol PCT context

For full PCT timing and dosing context, see the PCT guide.

Practical Summary

  • Liver support is non-negotiable — Tbol is 17α-alkylated; LIV.52 throughout the oral phase and ALT/AST at baseline, week 4, and cycle end are the minimum monitoring requirement; keep cycles at 6–8 weeks maximum; do not stack two 17α-alkylated orals simultaneously
  • No AI on solo Tbol cycles — Tbol produces zero E2 from its own metabolism; adding an AI without a testosterone base suppresses the already-limited estrogen pool unnecessarily; AI is only required when testosterone is part of the stack
  • PCT starts the day after the last tablet on solo cycles — ~16-hour half-life means the compound is effectively cleared within 24–48 hours; do not apply injectable PCT delay timing to a Tbol-only cycle; for combined cycles, PCT follows the injectable ester window
  • SHBG suppression is the reason to stack Tbol with testosterone, not to use it alone — the compound's most significant pharmacological advantage is displacing testosterone from SHBG and raising free testosterone; this benefit requires a testosterone base to be present; solo Tbol cycles forgo this synergy
  • Finasteride does not block Tbol's androgenic activity — 4-CDHMT does not convert to DHT; finasteride's 5AR inhibition has no effect on trenbolone's direct AR binding; if androgenic sides occur (acne, oily skin), address topically or with Accutane, not 5AR inhibitors
  • Detection window is long despite fast clearance — the active compound clears in 1–2 days but specific urinary metabolites remain detectable for 12+ months by modern accredited drug testing protocols; this is a compound-specific characteristic that significantly exceeds Tbol's pharmacologically active window

Turanabol Dragon Pharma remains one of the most practically versatile non-aromatizing oral AAS in the Dragon Pharma lineup — delivering meaningful lean mass, strength, and body composition benefits without E2 management complexity or DHT-pathway androgenic risk. For athletes building a first injectable cycle, steroidwarehouse.com's Turanabol 20 mg is a logical and well-understood kickstart that covers the induction phase while the injectable reaches steady state, with a safety and tolerability profile that distinguishes it clearly from aromatizing oral alternatives.

References

Source Topic Link
New England Journal of Medicine / PubMed Bhasin et al. 1996 — randomized controlled trial using 600 mg/week testosterone enanthate for 10 weeks, showing increased fat-free mass, muscle size, and strength, especially when combined with resistance training; foundational evidence for supraphysiologic androgen anabolic effects Bhasin S, et al. (1996) ↗
NCBI Bookshelf / StatPearls Anabolic steroids overview — synthetic testosterone-derived AAS pharmacology, androgen receptor mechanism, anabolic-androgenic effects, oral and injectable steroid classes, misuse patterns, monitoring, and adverse effect profile StatPearls: Anabolic Steroids ↗
NCBI Bookshelf / Endotext Androgen physiology and pharmacology — testosterone and androgen derivative mechanisms of action, androgen receptor activity, HPG axis suppression, 5α-reduction, estradiol aromatization, synthetic androgen pharmacology, and androgen misuse context Endotext: Androgen Physiology, Pharmacology, Use and Misuse ↗
Clinical Chemistry / PubMed Franke & Berendonk 1997 — historical analysis of the secret state-sponsored doping program of the German Democratic Republic; documents systematic androgenic-anabolic steroid administration to athletes and provides historical context for Oral Turinabol use in competitive sport Franke WW & Berendonk B (1997) ↗
British Journal of Pharmacology / PubMed Kicman 2008 — comprehensive review of anabolic steroid pharmacology, including mechanisms of action, androgen receptor biology, 17α-alkylation, oral activity, hepatotoxicity concerns, and anabolic-androgenic differentiation across compound classes Kicman AT (2008) ↗
What is Turanabol?

Turanabol is an oral anabolic steroid (4-Chlorodehydromethyltestosterone) for lean muscle; see What is Turanabol. It's effective—consult professionals for safe use.

How much Turanabol for bodybuilding?

20-60 mg/day for men, 5-20 mg/day for women; see How Much Turanabol for Bodybuilding. Start low—consult professionals for dosing.

How does Turanabol work?

It binds androgen receptors for lean muscle and strength; see Mechanism of Action. It delivers steady gains—monitor with labs.

What is Turanabol used for?

It's used for lean muscle, strength, and fat loss in cutting or lean bulking; see Key Benefits. It suits bodybuilders—use with professional oversight.

What are the main benefits of Turinabol?

Commonly reported benefits include lean muscle gains, improved strength, enhanced muscle endurance, and a "dry" physique appearance with minimal water retention.

Is Turinabol better for bulking or cutting?

Turinabol is often used for lean bulking or recomposition phases due to its steady gains and relatively dry, controlled physique outcomes.

What are the possible side effects of Turinabol?

Potential side effects may include liver stress (as it is an oral compound), changes in cholesterol levels, acne, and suppression of natural testosterone production.

What makes Turinabol different from other oral steroids?

Turinabol is known for producing slower, more controlled gains with less water retention and estrogenic activity compared to many other oral anabolic steroids.